KIT and acute myeloid leukemia: For example, it has been predicted that c-Kit is expressed in 80–90% of acute myelogenous leukemia (AML) cases and that coordinated activation of the c-Kit pathway and other oncogenic signaling pathways contribute to the severity of this cancer and other types of leukemias [27], [28].